Dr. Yogen Kanthi is a Lasker Investigator at the National Institutes of Health, and a practicing cardiologist and vascular medicine specialist. He leads a clinical and research program focused on understanding the role of inflammation in thrombogenesis. Dr. Kanthi’s research team were the first to describe innate immune hyperactivation and dysfunctional autoantibodies in COVID-19, which have led to numerous clinical trials. The long-term goal of his research program is to develop new treatments for highly morbid inflammatory and thrombotic diseases.
